Life After Invasive Meningococcal Disease: Insights from Survivors and Their Caregivers.

Autor: Herrera-Restrepo O; GSK, FMC Tower Suite 1700, 2929 Walnut St, Philadelphia, PA, 19104, USA. oscar.x.herrera-restrepo@gsk.com., Afroz N; IQVIA, Amsterdam, The Netherlands., Cabrera ES; GSK, Madrid, Spain., Reaney M; IQVIA, London, UK., Sowell FG; IQVIA, New York, NY, USA., Kumar R; IQVIA, Bangalore, India., Stillman A; American Society for Meningitis Prevention, Farmington Hills, MI, USA., Wukovits P; American Society for Meningitis Prevention, Farmington Hills, MI, USA., Rodrigues M; American Society for Meningitis Prevention, Farmington Hills, MI, USA., Pinto SB; GSK, Rio de Janeiro, Brazil., Kocaata Z; GSK, Wavre, Belgium., Onwude O; IQVIA, London, UK.

Publikováno v: Infectious diseases and therapy [Infect Dis Ther] 2024 Dec; Vol. 13 (12), pp. 2563-2579. Date of Electronic Publication: 2024 Oct 29.

Patient perspectives on symptoms, health-related quality of life, and treatment experience associated with relapsed/refractory multiple myeloma.

Autor: Nathwani N; Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope Medical Center, Duarte, CA, USA. nnathwani@coh.org., Bell J; Takeda Development Center Americas, Inc (TDCA), Lexington, MA, USA., Cherepanov D; Takeda Development Center Americas, Inc (TDCA), Lexington, MA, USA., Sowell FG; OPEN Health, Bethesda, MD, USA., Shah R; OPEN Health, Bethesda, MD, USA., McCarrier K; OPEN Health, Bethesda, MD, USA., Hari P; Medical College of Wisconsin, Milwaukee, WI, USA.

Publikováno v: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2022 Jul; Vol. 30 (7), pp. 5859-5869. Date of Electronic Publication: 2022 Apr 01.